¹«·á ·¹º§Å×½ºÆ® ¹Þ°í °­»çÆò°¡ ³²±â¸é 1,OOO¿ø ÄíÆù Áï½Ã Àû¸³!

Ȥ½Ã »çÀÌÆ®¿¡¼± ãÁö ¸øÇÑ ±Ã±ÝÇÑ Á¡ÀÌ ÀÖÀ¸¼¼¿ä?
³²°ÜÁֽŠÀ̸ÞÀÏÀ» ÅëÇØ ´äº¯ µå¸®°Ú½À´Ï´Ù.

¹®ÀÇÇϽг»¿ëÀÌ ¹®ÀÚ·Î ¹ß¼ÛµÇ¿À´Ï
¿¬¶ôó¸¦ ³²°ÜÁÖ¼¼¿ä.
¾÷¹«½Ã°£ ¿ù~±Ý ¿ÀÀü9½Ã~¿ÀÈÄ6½Ã
(Á¡½É½Ã°£ ³·12½Ã~¿ÀÈÄ1½Ã)

¿µÀÛ±³Á¤ °Ô½ÃÆÇ

¿µ¾î ¸»Çϱâ¿Í ¾²±â¸¦ µ¿½Ã¿¡ Àâ´Â´Ù!

ÀڽŠÀÖ°Ô ¾µ ¼ö ÀÖ´Â ¿µÀÛ¹®À» À§ÇØ ÆÄ¿öÀ×±Û¸®½¬ ¼ö¾÷À» ¼ö°­ÇϽôÂ
ȸ¿ø´Ôµé²² ¹«·á·Î Á¦°øÇص帮´Â ºÎ°¡ ¼­ºñ½º·Î, Àü¹® ºÐ¾ß¸¦ Á¦¿ÜÇÑ ÀÚÀ¯ ÁÖÁ¦
¶Ç´Â °­»ç´ÔÀÌ ³»Áֽô °úÁ¦¸¦ ȸ¿ø´Ô²²¼­ ¿µ¾î·Î ÀÛ¼ºÇØÁֽøé,
´ã´ç °­»ç ´Ô²²¼­ ¡®¹®¹ý ¿À·ù ±³Á¤¡¯ °ú ¡®´õ ³ªÀº ¿µ¾î½Ä Ç¥Çö¡¯À¸·Î ±³Á¤ÇØÁÖ´Â
¼­ºñ½º ÀÔ´Ï´Ù.

How would you influence someone to take the COVID 19 vaccine if they hesitate to take it. Share your

ÀÛ¼ºÀÚ: Á¤*¿ì
2021-08-25 296

ȸ¿ø´ÔÀÇ ¿µÀÛ¹®



Please see the attached file.

°­»ç´ÔÀÇ Ã·»è±³Á¤ ³»¿ë

Hi there Vicky! 


I am convinced by the statistics that you presented. If I could take another vaccine brand, I would get vaccinated as you bolstered your argument with statistics and concrete evidence of people who have taken the vaccine.


This however can be challenging to present to an ordinary person. In the media, they always say that the benefits of the vaccine outweigh the side effects. Of course not everyone will believe this but as of now,  if indeed the vaccine harms then a great portion of people have already died but that is not the case. Non-believers have the choice. You as a doctor may influence them more than anyone of us who know less about medicine.


Thank you for this answer and I shall see you in class for another discussion.


-T. Donna =)


The most common reason for hesitating to take COIVD 19 vaccine might be a risky side effects of vaccination, which are known to the general public by the media.

>> The most common reason for hesitating to take the COIVD 19 vaccine might be the risky side effects of the vaccination, which are known to the general public by the media.


 To persuade someone to take vaccination, I would start with relieving anxiety by suggesting the study results. The study published in The Lancet Infectious Diseases, used the data from 627383 users of the app, who self-reported systemic and local side effects. 

>>  To persuade someone to take the vaccination, I would start with relieving anxiety by suggesting the study results. The study published in The Lancet Infectious Diseases, used the data from 627383 users of the app, who self-reported systemic and local side effects. 


One in four people taken vaccines had mild systemic side effects (most common was headache (7.8%) following with muscle aches and fatigue) and local tenderness at the injection site(about 50%) The incidence of the side effects seems relatively high, but these are quite mild, and lasted no longer than 2 days.

>> One in four people who had taken vaccines had mild systemic side effects (most common was headache (7.8%) followed by muscle aches and fatigue), and local tenderness at the injection site(about 50%) The incidence of the side effects seem relatively high, but these are quite mild, and lasted no longer than 2 days.


 Moreover, Tim Spector's study showed that there was 58% reduction in infections 12 to 21 days after the first dose of Pfizer vaccine, 39% reduction after the AstraZeneca vaccine compared to controls. In conclusion, these results proved the effectiveness and the safety of the vaccination.

>>  Moreover, Tim Spector's study showed that there was a 58% reduction in infections 12 to 21 days after the first dose of Pfizer vaccine, 39% reduction after the AstraZeneca vaccine compared to controls. In conclusion, these results proved the effectiveness and the safety of the vaccination.


 Even though vaccinated person might experience side effects, these are not severe and self-limiting, but that person can be safe from COVID-19 virus, which might put one at risk for severe complications.

>>  Even though a vaccinated person might experience side effects, these are not severe and self-limiting, but that person can be safe from COVID-19 virus, which might put one at risk for severe complications.

¹øÈ£ Á¦¸ñ ±Û¾´ÀÌ °ø°³ »óÅ µî·ÏÀÏ Á¶È¸¼ö
110857 Summer ±â*Çö ¿Ï·á 2021-08-13 264
110856 It is generally accepted that families are not as close as they... ±è*¼ø ¿Ï·á 2021-08-13 271
110855 homework Á¤*¿î ¿Ï·á 2021-08-13 1
110854 What do you hope to learn or discover in your time abroad? -... ÀÌ*Çö ¿Ï·á 2021-08-13 283
110853 Homework ÀÓ*¹Î ¿Ï·á 2021-08-13 2
110852 English writing interview expected question\'s answer ÀÌ*Çö ¿Ï·á 2021-08-13 255
110851 Military to spend 37.52b won for done purchase next year À¯*Áø ¿Ï·á 2021-08-13 3
110850 Friday homework ·ù*¿ì ¿Ï·á 2021-08-13 338
110849 what kind of fashion do I want to try ¼Û*¾È ¿Ï·á 2021-08-13 0
110848 e-mail correction ¹Ú*±¤ ¿Ï·á 2021-08-13 3
110847 Page 30 ¿À*Àº ¿Ï·á 2021-08-13 453
110846 What is your favorite room in your house? Why? ³ë*ÀÌ ¿Ï·á 2021-08-13 2
110845 Homework Àå*Èñ ¿Ï·á 2021-08-13 289
110844 Homework °­*¼± ¿Ï·á 2021-08-13 342
110843 What are you crossing your fingers for? ÇÏ*Á¶ ¿Ï·á 2021-08-13 322
110842 I\'m living in dongtan ±è*¼º ¿Ï·á 2021-08-13 325
110841 Which do you appreciate more in music, theory or practice? Á¶*ÁÖ ¿Ï·á 2021-08-12 1
110840 Where is the best place for you to work? ¾È*À± ¿Ï·á 2021-08-12 2
110839 Where do young people in this country usually spend their free... ¹Ú*Çö ¿Ï·á 2021-08-12 283
110838 Do you think piano lessons are important for student\'s... ÇÏ*À± ¿Ï·á 2021-08-12 257

HOW TO USE IT?

[¸¶ÀÌÆäÀÌÁö > ¼ö¾÷ ³»¿ë º¸±â > ÇнÀ ͏°´õ > ¿µÀÛ±³Á¤ ¹öư Ŭ¸¯]

¼ö¾÷ Ƚ¼ö¸¸Å­ ¿µÀÛ±³Á¤ °Ô½ÃÆÇÀÌ »ý¼ºµÇ¸ç,
Áö³­ ³¯Â¥¿¡µµ °Ô½Ã ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ5ȸ ¼ö¾÷ : ¿ù 20ȸ ÀÌ¿ë °¡´É
ÁÖ3ȸ ¼ö¾÷ : ¿ù 12ȸ ÀÌ¿ë °¡´É
ÁÖ2ȸ ¼ö¾÷ : ¿ù 08ȸ ÀÌ¿ë °¡´É
01
±³Á¤ ³»¿ëÀº ÃÖ´ë 1,000byte±îÁö ¿Ã¸± ¼ö ÀÖ½À´Ï´Ù.

÷ºÎ ÆÄÀÏÀº ¿øÈ°ÇÑ Ã·»èÀ» À§ÇÑ Âü°íÀÚ·á·Î »ç¿ëµÉ »Ó,
ÆÄÀÏ¿¡ ´ëÇÑ Ã·»èÀº ºÒ°¡´É ÇÕ´Ï´Ù.

¾÷·Îµå °¡´ÉÇÑ Ã·ºÎ ÆÄÀÏÀº ÃÖ´ë 2mb±îÁöÀ̸ç,
÷ºÎ ÇÒ ¼ö ÀÖ´Â ÆÄÀÏ Çü½ÄÀº ´ÙÀ½°ú °°½À´Ï´Ù.

¹®¼­ - PDF, TXT, DOCX,
À̹ÌÁö - JPEG, PNG, GIF
02
Àü¹® ºÐ¾ß¸¦ Á¦¿ÜÇÑ È¸¿ø´ÔÀÌ Á÷Á¢ ÀÛ¼ºÇÑ ±Û¸¸
÷»èÀÌ °¡´ÉÇϸç,

¿Ã·ÁÁֽбÛÀÇ °­»ç´Ô ÷»èÀº 24½Ã°£ À̳»¿¡
¿Ï·á µÇ´Â °ÍÀ» ¿øÄ¢À¸·Î Çϰí ÀÖ½À´Ï´Ù.
03
ÇÏ·ç °Ô½Ã °¡´ÉÇÑ ±ÛÀº 3ȸ±îÁö À̸ç,
Á¾·áµÈ ¼ö¾÷ÀÇ ¿µÀÛ±³Á¤ °Ô½ÃÆÇÀº
ÀÌ¿ëÀÌ ¾î·Á¿î Á¡ ¾çÇØ ºÎŹ µå¸³´Ï´Ù.
04